Testa vår nya webbplats och uppdaterade nyhetsrum för att ta del av aktuella nyheter, rapporter och mycket mer.

Notice to Extraordinary General Meeting in Emplicure AB (publ)

Shareholders in Emplicure AB (publ), org.nr 556967-7189 ("Emplicure" or "the Company") are hereby convened to the Extraordinary General Meeting on Monday 14 November 2022 at 11 am at the Company's premises, Virdings allé 32B, Uppsala.

Notification etc.

Shareholders who wish to participate at the Extraordinary General Meeting must:

  • be registered in their own name (not nominee-registered) in the share register kept by Euroclear Sweden AB on Friday 4 November 2022, and
  • notify their participation so that the notification is received by the Company no later than Thursday 10 November 2022 via e-mail to [email protected]

Such notification shall include the shareholder's name, personal identification number or company registration number (or similar), address and daytime telephone number, number of shares, details on advisors (no more than two), if any, and where applicable, details of representatives or proxies.

Nominee-registered shares

In order to be entitled to vote and participate at the general meeting, shareholders whose shares are registered in the name of a nominee must notify their participation and temporarily re-register their shares in their own names in the share register maintained by Euroclear Sweden AB the record date of the Extraordinary General Meeting. Shareholders must therefore advise their nominees well in advance of such date. Voting rights registration which have been requested by the shareholders at such time that the registration has been done by nominee not later than Tuesday 8 November 2022 will be considered when producing the share register.

Proxy

Shareholders represented by proxy must submit a dated proxy. If the proxy is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The proxy may not be valid for a period longer than five years from its issuance. The original proxy and certificate of registration should be submitted to the Company by post at the address mentioned above in due time prior to the general meeting. The Company provides a proxy form at request, and it is also available at the Company's website, www.emplicure.com.

Number of Shares and votes

At the time of issuing this notice, there are a total of 26,460,512 shares in the Company. The total number of votes amounts to 26,460,512. The Company does not hold any shares in itself.

Proposed agenda

  1. Opening of the general meeting and election of chairman of the general meeting
  2. Preparation and approval of the voting list
  3. Election of one or two persons to verify the minutes
  4. Approval of the agenda
  5. Determination as to whether the meeting has been duly convened
  6. Resolution on approval of the transfer of shares in the subsidiary Amplicon AB to Amplicon's CEO Thomas Hammargren
  7. Closing of the general meeting

Proposals to resolutions

Item 6 - Resolution on approval of the transfer of shares in the subsidiary Amplicon AB to Amplicon's CEO Thomas Hammargren

The board's assessment is that Tomas Hammargren, the CEO of the Company's subsidiary Amplicon AB ("Amplicon"), is of great importance to Amplicon's further development and the successful commercialization of the products developed by Amplicon. The board therefore believes that it is important and in the interests of all shareholders that Tomas Hammargren has a personal long-term ownership commitment in Amplicon, which can be expected to contribute to an increased interest in Amplicon's operations and earnings development as well as increase the CEO's motivation and align interests with the Company and its shareholders.

Therefore, the board of Emplicure, conditional on the approval of the general meeting, has decided to offer Tomas Hammargren to acquire shares in Amplicon according to the following conditions:

  • Tomas Hammargren or a company wholly owned by Tomas Hammargren is offered to acquire 1,250 shares in Amplicon, corresponding to five percent of the total number of outstanding shares in Amplicon.
  • The price for the shares amounts to a total of SEK 805,000, which corresponds to the board's assessment of the market value of the shares. The board's assessment is based on a valuation of Amplicon carried out by BDO on behalf of the Company.
  • The transfer must be conditional on Emplicure and Tomas Hammargren entering into a customary shareholder agreement.

The transfer requires the approval of the general meeting in Emplicure according to chapter 16 in the Companies Act. The board proposes that the general meeting resolves to approve the transfer of shares in Amplicon to Thomas Hammargren or a company wholly owned by Thomas Hammargren on the terms stated above. For its validity, the resolution requires the support of shareholders with at least nine tenths (9/10) of both the votes cast and the shares represented at the meeting.

Information at the Extraordinary General Meeting

The board of directors and the managing director shall, upon request by any shareholder and where the board of directors determines that it can be done without material harm to the Company, provide information of circumstances which may affect the assessment of a matter on the agenda.

Documentation  

Documents according to the Swedish Companies Act will, where applicable, be held available at the Company's office with address Virdings allé 32B, 754 50 Uppsala no later than two weeks before the meeting, at the latest 31 October 2022. The documents will also be sent, without charge, to shareholders who so request and inform the Company of their postal address. The documents will also be held available at the extraordinary general meeting.

 

Uppsala in October 2022

Emplicure AB (publ)

The board of directors

For additional information, please contact

Håkan Engqvist

CEO
Phone: +46 702 569 500
Email: [email protected]

Erik Magnusson

CFO
Phone: +46 708 565 245
Email: [email protected]

Certified Adviser

Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank.

Emplicure develops new and innovative products by combining existing and approved active substances with advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain and on abuse-deterrent formulations. The subsidiary Amplicon AB develops consumer products with oral nicotine as the first product. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com

Emplicure och OnDosis samarbetar för att utveckla bättre behandlingar för smärta

Emplicure AB och OnDosis AB utvärderar gemensamma utvecklingsmål för oral dosering av aktiva ingredienser baserade på bolagens respektive kärnkompetenser inom formulering och dosering.


Emplicure and OnDosis form partnership to develop better pain treatments

Emplicure and OnDosis will jointly evaluate development targets for oral delivery of active ingredients, based on their respective core competencies in formulation and dosing.


Emplicure meddelar resultat från den explorativa kliniska farmakokinetiska studien på sin läkemedelskandidat Empli03

Emplicure AB, företaget som kombinerar egen teknologi med beprövade substanser och ingredienser för att utveckla nya konsument- och läkemedelsprodukter, tillkännager idag topline-resultat från en explorativ farmakokinetisk studie med Empli03 på friska försökspersoner.


Emplicure announces results from the exploratory clinical PK study of its drug candidate Empli03

Emplicure, the company that combines proprietary technology with tried and tested substances and ingredients to develop new consumer and pharmaceutical products, today announces top-line results from an exploratory pharmacokinetic study with Empli03 in healthy volunteers


Emplicure anlitar Erik Penser Bank som likviditetsgarant

Emplicure AB (publ) har utsett Erik Penser Bank AB ("Penser") till likviditetsgarant för Bolagets aktie. Syftet är att förbättra aktiens likviditet och Pensers uppdrag inleds den 24 november 2022.


Emplicure engages Erik Penser Bank as liquidity provider

Emplicure AB (publ) today announced that the company has entered into an agreement with Erik Penser Bank ("Penser") whereby Penser will act as liquidity provider for the Emplicure share, starting 24 November 2022.




Kommuniké från extra bolagsstämma i Emplicure AB (publ)

Extra bolagsstämma i Emplicure AB (publ) ("Bolaget") ägde rum kl. 11.00 måndagen den 14 november 2022 i Bolagets lokaler, Virdings allé 32B, Uppsala.


Communiqué from extraordinary general meeting in Emplicure AB (publ)

An extraordinary general meeting in Emplicure AB (publ) (the "Company") was held on Monday 14 November 2022 at 11 am at the Company's premises, Virdings allé 32B, Uppsala.


Emplicure upptar lån om 9,0 MSEK

Emplicure AB (publ) har idag ingått ett låneavtal med ett konsortium av långivare genom vilket Bolaget upptagit ett lån om 9,0 MSEK. Lånekonsortiet inkluderar vissa befintliga aktieägare, däribland styrelseledamoten Johan Wieslander. Syftet med lånet är att kortsiktigt stärka bolagets rörelsekapital samt att möta kravet på befintligt aktiekapital för att driva bolaget den närmaste tolvmånadersperioden.


Emplicure takes up a loan in the amount of 9.0 MSEK

Emplicure AB (publ) has today entered into a loan agreement with a loan consortium through which the Company has taken up a loan in the amount of 9.0 MSEK. The loan consortium includes certain existing shareholders, including the board member Johan Wieslander. The purpose of the loan is to strengthen the Company's short-term working capital and to meet the requirement of going concern for the next twelve months.




Emplicure utser valberedning

Emplicure AB meddelar idag att valberedningen har utsetts inför stämman i maj 2023. Valberedningen består av representanter för de tre största aktieägarna per den sista bankdagen i tredje kvartalet, jämte styrelsens ordförande. Bolagets tre största aktieägare, tillika grundare, har enats om att rösta som en genom Thomas Lundqvist, för att ge företräde till oberoende aktieägare.


Emplicure has formed Nomination Comittee

Emplicure AB announces today that the Nomination Committee for the annual general shareholders meeting (AGM) in May 2023 is formed. The Nomination Committee  consists of representatives nominated by the three largest shareholders per the last bank-day in the third quarter, as well as the Chairman of the Board. Emplicure's three largest shareholders, also the founders, have agreed to vote as one, in order to give preference for more shareholders.


Dosering i fas I PK-studie för EMPLI03 slutförd

Emplicure AB rapporterar genomförd dosering i den första fas I farmakokinetikstudien med EMPLI03, avsedd för behandling av medelsvår till svår smärta


Dosing in Phase I PK study for EMPLI03 completed

Emplicure AB today reported dosing in the first Phase I pharmacokinetic study for EMPLI03, intended for the treatment of moderate to severe pain


Emplicure byter Certified Adviser till Erik Penser Bank AB

Uppsala 2022-10-03 Emplicure AB (publ) meddelade idag att bolaget byter Certified Adviser


Emplicure changes Certified Adviser to Erik Penser Bank AB

Uppsala, 2022-10-03 Emplicure AB (publ) today announced that the company changes Certified Adviser


Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted